Hamid Masoudi

Author PubWeight™ 19.85^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).	Blood	2005	2.69
2	Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.	Cancer Res	2008	2.37
3	Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.	Cancer Res	2008	1.82
4	Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.	Breast Cancer Res	2008	1.25
5	Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment.	Ann Surg Oncol	2006	1.13
6	HLA-DR protein status predicts survival in patients with diffuse large B-cell lymphoma treated on the MACOP-B chemotherapy regimen.	Leuk Lymphoma	2007	1.09
7	Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma.	Arch Surg	2007	1.05
8	Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.	Am J Surg	2006	1.00
9	Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.	Ann Surg Oncol	2008	0.98
10	HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients.	Ann Surg	2010	0.94
11	Clinical utility of type 1 growth factor receptor expression in colon cancer.	Am J Surg	2008	0.91
12	beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.	Genes Chromosomes Cancer	2005	0.89
13	Beta-catenin expression is prognostic of improved non-small cell lung cancer survival.	Am J Surg	2012	0.88
14	Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.	Ann Surg Oncol	2007	0.83
15	BCL-2 expression is prognostic for improved survival in non-small cell lung cancer.	J Thorac Oncol	2009	0.82
16	Evaluation of type 1 growth factor receptor family expression in benign and malignant thyroid lesions.	Am J Surg	2008	0.79
17	Anaplastic thyroid carcinoma exhibits intratumoral molecular homogeneity for a therapeutic target panel.	Anticancer Res	2009	0.77